UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 179 filers reported holding UNIQURE NV in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,009,525 | -39.7% | 297,267 | +0.2% | 0.00% | -40.0% |
| Q2 2023 | $3,330,298 | -41.0% | 296,818 | +5.0% | 0.01% | -37.5% |
| Q1 2023 | $5,640,456 | -11.8% | 282,588 | -0.7% | 0.01% | -20.0% |
| Q4 2022 | $6,393,104 | +23.7% | 284,644 | +2.5% | 0.01% | +25.0% |
| Q3 2022 | $5,167,000 | +2.3% | 277,668 | -0.3% | 0.01% | +14.3% |
| Q2 2022 | $5,052,000 | -0.2% | 278,526 | +0.8% | 0.01% | +16.7% |
| Q1 2022 | $5,060,000 | -13.7% | 276,375 | +1.3% | 0.01% | -14.3% |
| Q4 2021 | $5,863,000 | -34.2% | 272,781 | -1.5% | 0.01% | -41.7% |
| Q3 2021 | $8,912,000 | +28.3% | 276,931 | +22.8% | 0.01% | +33.3% |
| Q2 2021 | $6,944,000 | – | 225,467 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |